Hypoxia increases antibiotic resistance in Pseudomonas aeruginosa through altering the composition of multidrug efflux pumps

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 2114-2118

  Schaible, Bettina ^a   Taylor, Cormac T ^a   Schaffer, Kirsten ^b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

2 NAPHTHYLAMINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; MESSENGER RNA; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; CELL DIVISION; CONTROLLED STUDY; HYPOXIA; MINIMUM INHIBITORY CONCENTRATION; NODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; STOICHIOMETRY;

ANAEROBIOSIS; ANOXIA; ANTI-BACTERIAL AGENTS; BIOFILMS; CYSTIC FIBROSIS; DIPEPTIDES; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENZYME ACTIVATION; MICROBIAL SENSITIVITY TESTS; MIXED FUNCTION OXYGENASES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84858692238     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05574-11     Document Type: Article

References (21)

1. Alvarez-Ortega C, Harwood CS. 2007. Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol. Microbiol. 65:153-165. (Pubitemid 46934486)
2. Beinlich KL, Chuanchuen R, Schweizer HP. 2001. Contribution of multidrug efflux pumps to multiple antibiotic resistance in veterinary clinical isolates of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 198:129-134. (Pubitemid 32411555)
3. Bittar F, et al. 2008. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PLoS One 3:e2908.
4. Colgan SP, Taylor CT. 2010. Hypoxia: an alarm signal during intestinal inflammation. Nat. Rev. Gastroenterol. Hepatol. 7:281-287.
5. Comerford KM, et al. 2002. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62:3387-3394. (Pubitemid 34651384)
6. Cummins EP, et al. 2008. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134:156-165.
7. Dumas JL, van Delden C, Perron K, Kohler T. 2006. Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR. FEMS Microbiol. Lett. 254:217-225.
8. Henrichfreise B, Wiegand I, Pfister W, Wiedemann B. 2007. Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob. Agents Chemother. 51:4062-4070. (Pubitemid 350057805)
9. Kaelin WG, Jr, Ratcliffe PJ. 2008. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30:393-402. (Pubitemid 351681994)
10. Kowalski RP, et al. 2005. An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data. Ophthalmology 112:1987.
11. Loenarz C, et al. 2011. The hypoxia-inducible transcription factor pathway regulates oxygen sensing in the simplest animal, Trichoplax adhaerens. EMBO Rep. 12:63-70.
12. Marteyn B, et al. 2010. Modulation of Shigella virulence in response to available oxygen in vivo. Nature 465:355-358.
13. Poole K, et al. 1996. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21:713-724. (Pubitemid 26281520)
14. Poole K, Srikumar R. 2001. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr. Top. Med. Chem. 1:59-71.
15. Ratjen F, Döring G. 2003. Cystic fibrosis. Lancet 361:681-689. (Pubitemid 36246556)
16. Schaible B, Schaffer K, Taylor CT. 2010. Hypoxia, innate immunity and infection in the lung. Respir. Physiol. Neurobiol. 174:235-243.
17. Taylor CT. 2008. Interdependent roles for hypoxia inducible factor and nuclear factor-≲καππα∀B in hypoxic inflammation. J. Physiol. 586:4055-4059.
18. van Berkel WJ, Kamerbeek NM, Fraaije MW. 2006. Flavoprotein monooxygenases, a diverse class of oxidative biocatalysts. J. Biotechnol. 124:670-689. (Pubitemid 44066596)
19. Walters MC, III, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. 2003. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47:317-323. (Pubitemid 36070381)
20. Worlitzsch D, et al. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:317-325. (Pubitemid 34141805)
21. Yoneda K, et al. 2005. Measurement of Pseudomonas aeruginosa multidrug efflux pumps by quantitative real-time polymerase chain reaction. FEMS Microbiol. Lett. 243:125-131. (Pubitemid 40164398)